The funding builds on more than $1.7 million already awarded to the firm, which is building a diagnostic for characterizing patients in clinical trials.
The company plans to develop a liquid biopsy assay that can identify patients most likely to benefit from treatment with checkpoint inhibitors.
Mathais Lichterfeld of the Ragon Institute and Rushdy Ahmad of the Broad Institute will use high-throughput proteomics to find phosphorylation important to HIV replication.
NIH has been conservative on the PMI's budget and its funds are sufficient to launch enrollment next year, begin collecting data, and initiate genetic testing pilot projects.
Personalized medicine proponents are uncertain where funding, personnel, and priorities will land in a new administration and Congress.
Translational scientist Jacqueline Achkar of Albert Einstein Medical College will lead several collaborations to build a point-of-care diagnostic platform.
The VP lauded the work of the assembled researchers, offered suggestions for ways forward, and asked for their help in determining how to change the system for the better.
The grants are strictly for new research, but Rice University scientist David Zhang is always looking for commercialization opportunities with his startup, Searna.
The grant will support the day-to-day running, maintenance, and care of the supercomputer through the year 2020.
President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.